Evidence map›Paper›PMID 20015201›Full record

ArticleJournal of cellular and molecular medicine2011

Expression of NPP1 is regulated during atheromatous plaque calcification.

Yvonne Nitschke, Simone Hartmann, Giovanni Torsello, Rüdiger Horstmann, Harald Seifarth, Gabriele Weissen-Plenz, Frank Rutsch

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. ENPP1 Immunobiology as a Therapeutic Target.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Review
  2. Review
  3. Review
  4. Calcium Signaling and Tissue Calcification.Cold Spring Harbor perspectives in biology · 2019
    Review
  5. Review
  6. Article
  7. Regulatory circuits controlling vascular cell calcification.Cellular and molecular life sciences : CMLS · 2013
    Review
  8. Article
  9. Npp1 promotes atherosclerosis in ApoE knockout mice.Journal of cellular and molecular medicine · 2011
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yvonne NitschkeDepartment of General Pediatrics, Münster University Children's Hospital, Münster, Germany.
Simone Hartmann
Giovanni Torsello
Rüdiger Horstmann
Harald Seifarth
Gabriele Weissen-Plenz
Frank Rutsch
University Hospital Münster · DEZero to Three · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations of the ENPP1 gene encoding ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) are associated with medial calcification in infancy. While the inhibitory role of matrix proteins such as osteopontin (OPN) with respect to atherosclerotic plaque calcification has been established, the role of NPP1 in plaque calcification is not known. We assessed the degree of plaque calcification (computed tomography), NPP1 and OPN localization (immunohistochemistry) and expression (RT-PCR) in a cohort of 45 patients undergoing carotid endatherectomy for significant stenosis of the internal carotid artery and in normal arteries (N= 50). We correlated NPP1 and OPN expression levels to the degree of plaque calcification, to pro-atherogenic factors and statin therapy. NPP1 was demonstrated in the base and in the shoulder of atherosclerotic plaques. Compared to normal arteries and non-calcified plaques, in calcified plaques NPP1 mRNA was decreased (P < 0.0001). OPN mRNA levels were up-regulated in carotid atheroma. NPP1 and OPN expression levels positively correlated with the degree of plaque calcification (R= 0.54, P= 0.00019 and R= 0.46, P= 0.017, respectively) and with risk factors of atherosclerosis. Expression of the calcification inhibitor NPP1 is down-regulated in calcified atherosclerotic plaques. Our correlation data point to a counter-active mechanism, which in the end turns out to be insufficient to prevent further progression of calcification.

Indexed as

AgedAged, 80 and overAtherosclerosisCarotid ArteriesCarotid Artery DiseasesCarotid StenosisDown-RegulationFemaleHumansMaleMiddle AgedMuscle, Smooth, VascularOsteopontinPhosphoric Diester HydrolasesPlaque, AtheroscleroticPyrophosphatasesectonucleotide pyrophosphatase phosphodiesterase 1OsteopontinPhosphoric Diester HydrolasesPyrophosphatasesRNA, Messenger

Identifiers

PMID20015201
PMCPMC3822790
OpenAlexW2067654583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.